MedPath

Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine

Phase 4
Terminated
Conditions
Thoracic Surgery
Interventions
Registration Number
NCT01320475
Lead Sponsor
Hopital Foch
Brief Summary

Thoracic epidural analgesia is often proposed to thoracotomized patients. A local anesthetic and an opioid are generally associated to produce an epidural analgesia. However, opioid epidural administration is frequently associated with adverse effects as nausea, vomiting, urinary retention, ... On the other hand, iv ketamine has been demonstrated to be an effective analgesic.

The purpose of the study is to compare the epidural administration of levobupivacaine and sufentanil or the epidural administration of levobupivacaine associated with the iv administration of ketamine.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • age between 18 and 75 yrs
  • class ASA I, II or III
  • lung surgery
Exclusion Criteria
  • Contra-indication to the achievement of epidural analgesia
  • Preoperative chronic pain,
  • Contra-indication to ketamine
  • Hypersensitivity to ketamine or any excipients
  • Uncontrolled hypertension,
  • Stroke
  • Heart failure
  • Hepatic porphyria
  • Contra-indication to sufentanil
  • Hypersensitivity to sufentanil, opioids or any excipients
  • Treatment with an opioid agonist-antagonist,
  • Contra-indication to levobupivacaine
  • Hypersensitivity to levobupivacaine, local anesthetics of the amide or any excipients
  • Hypotension, shock

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
iv KetamineKetamineEpidural infusion of levobupivacaine and saline (placebo for sufentanil)and iv infusion of ketamine Up to the third postoperative day (6 PM)
SufentanilSufentanilEpidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)
Primary Outcome Measures
NameTimeMethod
Efficacy of the analgesic regimenthird postoperative day
Occurrence of an adverse event due to the analgesic protocolone week
Secondary Outcome Measures
NameTimeMethod
postoperative complications (pulmonary, others)one month
length of stayone month
patient's satisfactionsortie de l'hopital
postoperative rehabilitationtwo weeks
Occurence of a chronic painend the first postoperative year

Trial Locations

Locations (1)

Hopital Foch

🇫🇷

Suresnes, France

© Copyright 2025. All Rights Reserved by MedPath